Cardlytics (CDLX) Reports In-Line Q2 EPS

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.39), in-line with the analyst estimate of ($0.39). Revenue for the quarter came in at $58.9 million versus the consensus estimate of $62.81 million.

GUIDANCE:

Cardlytics sees Q3 2021 revenue of $57-66 million, versus the consensus of $71 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• L3Harris CEO steps down amid conduct review, shares drop